Not all patients with CLL require therapy. Even with all modern innovations, the iwCLL nonetheless recommends watchful observation for sufferers with asymptomatic disorder.86 This advice is predicated on at least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Partisipasi aktif dari masyarakat dalam https://kingi159frd6.wikihearsay.com/user